Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas G Graeber

Showing results (31-40 of 132) with videos related to

Pageof 14
Sort By:
Molecular Cancer Research : MCR|February 3, 2016
The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine CarcinomaWei Li, Alexa Cohen, Yin Sun, et al.
Science Signaling|March 31, 2011
Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signalingLiudmilla Rubbi, Björn Titz, Lauren Brown, et al.
Cancer Cell|May 31, 2011
Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growthDavid J Mulholland, Linh M Tran, Yunfeng Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2015
MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cellsDiego Ploper, Vincent F Taelman, Lidia Robert, et al.
The Prostate|April 25, 2003
Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor systemStephen J Freedland, Allan J Pantuck, Sun H Paik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2014
Effects of MAPK and PI3K pathways on PD-L1 expression in melanomaMohammad Atefi, Earl Avramis, Amanda Lassen, et al.
Cancer Research|June 14, 2012
BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapyRichard C Koya, Stephen Mok, Nicholas Otte, et al.
Journal of Translational Medicine|April 7, 2019
Interleukin 32 expression in human melanomaHelicia Paz, Jennifer Tsoi, Anusha Kalbasi, et al.
Science Translational Medicine|March 20, 2015
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanomaSiwen Hu-Lieskovan, Stephen Mok, Blanca Homet Moreno, et al.
Cell Reports|September 21, 2018
A Human Adult Stem Cell Signature Marks Aggressive Variants across Epithelial CancersBryan A Smith, Nikolas G Balanis, Avinash Nanjundiah, et al.
Pageof 14

Showing results (31-40 of 132) with videos related to

Sort By:
Pageof 14
Molecular Cancer Research : MCR|February 3, 2016
The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine CarcinomaWei Li, Alexa Cohen, Yin Sun, et al.
Science Signaling|March 31, 2011
Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signalingLiudmilla Rubbi, Björn Titz, Lauren Brown, et al.
Cancer Cell|May 31, 2011
Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growthDavid J Mulholland, Linh M Tran, Yunfeng Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2015
MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cellsDiego Ploper, Vincent F Taelman, Lidia Robert, et al.
The Prostate|April 25, 2003
Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor systemStephen J Freedland, Allan J Pantuck, Sun H Paik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2014
Effects of MAPK and PI3K pathways on PD-L1 expression in melanomaMohammad Atefi, Earl Avramis, Amanda Lassen, et al.
Cancer Research|June 14, 2012
BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapyRichard C Koya, Stephen Mok, Nicholas Otte, et al.
Journal of Translational Medicine|April 7, 2019
Interleukin 32 expression in human melanomaHelicia Paz, Jennifer Tsoi, Anusha Kalbasi, et al.
Science Translational Medicine|March 20, 2015
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanomaSiwen Hu-Lieskovan, Stephen Mok, Blanca Homet Moreno, et al.
Cell Reports|September 21, 2018
A Human Adult Stem Cell Signature Marks Aggressive Variants across Epithelial CancersBryan A Smith, Nikolas G Balanis, Avinash Nanjundiah, et al.
Pageof 14